The foramen ovale (FO) between the right and left atria provides the only pathway for oxygenated maternal blood to enter the left heart and upper body of the fetus.
valve morphology and Doppler function and presence of pericardial effusion or ascites were assessed. The end-systolic phase was identified as the frame prior to atrioventricular valve closure and the frame prior to semilunar valve opening and the diameter of variable was at its maximum; the end-diastolic phase was identified as the frame prior to atrioventricular valve opening and the frame prior to semilunar valve closure and the diameter of variable was at its maximum, respectively. All dimensions were measured three times, and the average value was used.
The FO was evaluated in four-chamber views, sagittal bicaval views, or long-axis views of the aortic arch using 2D and color Doppler echocardiography. The maximum dimension of the FO was measured by 2D echocardiography under the guidance of color Doppler echocardiography. The pulse Doppler value was recorded as well.
The diagnosis of fetuses with restrictive FO was made on the basis of previously published criteria: (1) FO diameter < 2.5 mm 
| Equipment
All ultrasound examinations were performed by experienced operators using the General Electric Voluson E8 ultrasound system with transabdominal 2-to 4-MHz curvilinear transducers (GE Healthcare Ultrasound, Milwaukee, WI, USA) or the Aloka SSD ultrasound system (Aloka, Tokyo, Japan) using transabdominal 3-to 6-MHz curvilinear transducers. 
| Statistics

| RE SULTS
In this large, single-institution cohort, 9704 fetal echocardiograms were available for analysis ( Figure 2 ). Among them, 2997 fetuses had structural congenital heart disease. A total of 6707 (69.1%) fetuses had structurally normal hearts and without extra-cardiac abnormality, of which 60 (0.89%) had rFO and 5 (0.07%) had cFO.
Thus, the percentage of rFO/cFO in structurally normal hearts was 0.97%. The mean maternal age for the fetuses with rFO/cFO was 28.1 ± 3.7 years (range, 19-41 years), and the mean gestational age for the fetuses with rFO/cFO seen with echocardiography was 33.9 ± 4.3 weeks (range 23-37 weeks, median 34 weeks). 
| Fetal echocardiographic characteristics
| Fetal and postnatal mortality and morbidity
Neonatal death occurred in 3 cases, and 11 fetuses were lost to follow-up. In the rest of the cohort, 51 fetuses with rFO/cFO had good outcome after birth ( Figure 2 ).
Among fetuses with rFO (n = 60), neonatal death occurred in 1 (1.67%); 10 were lost to follow-up (16.66%). Forty-nine (81.67%) survived with normal heart or minor heart defects (1 with a small secundum atrial septal defect vs patent FO (1.3 mm), 1 with small perimembraneous ventricular septal defect (1.5 mm), and 1 with patent ductus arteriosus) ( Figures 3,4 ).
In contrast, among the fetuses with cFO (n = 5), 2 neonatal deaths occurred (40%), 1 was lost to follow-up (20%), and 2 survived with no heart abnormalities (40%). Of the three fetuses who died after delivery, two had cFO, and one had rFO (Table 2) .
Of the three fetuses who died after delivery, patient #1 had cFO with no flow across the FO ( 
| D ISCUSS I ON
Premature rFO/cFO in an otherwise structurally normal heart in a fetus is rare. Our study showed that premature rFO/cFO seen on fetal echocardiograms are associated with right atrial and ventricular dilation, tricuspid regurgitation, and pericardial effusion. Most fetuses had a good outcome, but there was an association between rFO/cFO and neonatal mortality and morbidity, which is worthy of further discussion.
Hansmann and Redel first described premature rFO/cFO in 1982. 16 Since then, anecdotal reports and small series have been published. The incidence is estimated to be 0.2%-1.4%. 10, 17, 18 To the best of our knowledge, this study is the largest to date. Our results suggest that premature rFO/cFO occurred in 0.97% of 6707 otherwise structurally normal fetuses in our cohort, which is similar to the findings of Uzun et al.
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F I G U R E 2 Results of fetal echocardiographic analysis of the study population In this study, the cases of rFO/cFO in otherwise structurally normal hearts were found in 33.9 ± 4.3 weeks (range 23-37). In normal human fetuses, the FO grows progressively until 30 weeks of gestation. Afterward, it continues to enlarge at a slower rate until term. 11, 12, 19 The pathogenesis of rFO/cFO is not clear. Pinette et al 20 suggested that rFO/cFO may be due to abnormal growth of the connective tissue in the fetal heart, ie, the interatrial septum and atrioventricular valves. It is postulated that rFO found in later gestation is associated with a good postnatal outcome. Gupta et al 8 showed that fetuses with only rFO in an otherwise structurally normal heart had no symptom other than a delayed drop in pulmonary arterial pressure that required no intervention. The pulmonary pressure trends to normalize within 2 weeks after birth. Our study showed all of the fetuses with rFO/cFO except 3 (95.4%) had no significant heart abnormality after delivery. For patient #1, who died on day 1 after delivery, it was noted that there was ascites and bowel infection.
It was speculated that the cause of death was due to necrotizing enterocolitis and intestinal perforation in utero. Patient #2, who was delivered at 28 gestational weeks and died after 4 days, showed a cFO with severe mitral and tricuspid regurgitation, dilated LV(13.9 mm) and RV (15.6 mm), decreased systolic function of the left and right ventricles, moderate pericardial effusion, severe pleural effusion, and severe ascites. It was speculated that the reasons for death were myocardiopathy and related valve insufficiency, which may have led to fetal hydrops. For patient #3, no cardiac defect was noted on the fetal echocardiograms except for a dilated right atrium and a rFO. However, it was noted that there was maternal preeclampsia and placental abruption, which may cause neonatal demise. In summary, most fetuses with rFO/cFO had good clinical neonatal outcome. There was an association between rFO/ cFO and neonatal mortality and morbidity, but the subgroup of patients also had prematurity, maternal preeclampsia and placental abruption, hydrops fetalis, and necrotizing enterocolitis with perforation, which may contribute directly to the neonatal demise.
There are limitations in our study. First, it is a single-institutional retrospective study. Many patients were referred to us from other centers; there is potential patient selection bias and the data and results may not be directly applicable to other centers and populations. Second, although this is one of the largest cohorts of fetuses with rFO/cFO, the sample size is relatively small, especially for the fetuses with poor outcome, which limited the statistical analysis and results of the study. Third, because many patients returned to their previous centers for follow-up after they were referred to us for fetal echocardiography, consultation and a second opinion, a subset of patients was lost to follow-up. There is also a lack of longitudinal and complete fetal and postnatal echocardiography as well as specific clinical outcome data.
| CON CLUS IONS
Premature rFO/cFO are rare in fetuses with otherwise structurally normal hearts. The fetal echocardiographic characteristics include right atrial and ventricular dilated, tricuspid regurgitation, and pericardial effusion. Most fetuses had a good outcome, although there was an association between rFO, especially cFO, with neonatal morality and complications (prematurity, maternal preeclampsia and placental abruption, hydrops fetalis, and necrotizing enterocolitis with perforation). 
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